![](/img/cover-not-exists.png)
A264 Phase I Study of Elotuzumab (HuLuc63) in Combination with Bortezomib in Relapsed Multiple Myeloma
Jakubowiak, AJ, Bensinger, W, Zimmerman, T, Chanan-Khan, A, Singhal, A, Siegel, D, Anderson, KCVolume:
9
Language:
english
Journal:
Clinical Lymphoma and Myeloma
DOI:
10.1016/s1557-9190(11)70526-1
Date:
February, 2009
File:
PDF, 89 KB
english, 2009